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A case of food-borne botulism occurred in Slovakia in 
2015. Clostridium botulinum type A was isolated from 
three nearly empty commercial hummus tubes. The 
product, which was sold in Slovakia and the Czech 
Republic, was withdrawn from the market and a warn-
ing was issued immediately through the European 
Commission’s Rapid Alert System for Food and Feed 
(RASFF). Further investigation revealed the presence 
of botulinum neurotoxin (BoNT) subtype BoNT/A3, a 
very rare subtype implicated in only one previous out-
break (Loch Maree in Scotland, 1922). It is the most 
divergent subtype of BoNT/A with 15.4% difference 
at the amino acid level compared with the prototype 
BoNT/A1. This makes it more prone to evading immu-
nological and PCR-based detection. It is recommended 
that testing laboratories are advised that this subtype 
has been associated with food-borne botulism for the 
second time since the first outbreak almost 100 years 
ago, and to validate their immunological or PCR-based 
methods against this divergent subtype.
Introduction
The life-threatening illness botulism is caused by seven 
serotypes (A-G) of botulinum neurotoxins (BoNT), how-
ever only serotypes A, B, E and F cause disease in 
humans. BoNTs prevent neurotransmitter release and 
lead to a flaccid paralysis. There are three main forms 
of human botulism: food-borne, wound and infant bot-
ulism [1,2]. The BoNTs are produced by six phylogeneti-
cally and physiologically distinct bacteria (Clostridium 
botulinum Groups I–IV, and strains of C. baratii and C. 
butyricum) which are so diverse as to merit classifi-
cation as different species. All of the BoNT-producing 
Clostridium species have non BoNT-producing coun-
terparts (not harbouring the BoNT gene cluster) which 
are often assigned to different species names, such 
as C. sporogenes for C. botulinum Group I strains [2]. 
This polyphyly of C. botulinum together with its close 
relationship to non-toxigenic species can result either 
in the erroneous detection of toxigenic Clostridium 
species or failure thereof.
The BoNT gene cluster is often associated with mobile 
genetic elements, allowing for interconversion between 
toxigenic and nontoxigenic Clostridium species, and 
leading to substantial variation in BoNT sequences and 
their genomic backgrounds [3]. Today, the BoNT sero-
types are divided into more than 40 subtypes, includ-
ing BoNT/A1 to BoNT/A8 [4], and mosaic forms [5]. The 
BoNT diversity at the amino acid level can reach up to 
36% within a serotype and is reflected by differences 
in their catalytic activity, receptor binding or pharma-
cokinetics [6]. In addition to containing the gene for 
BoNT, the BoNT gene cluster contains the gene for the 
non-toxic non-haemagglutinin (NTNH) protein. The 
BoNT gene cluster also harbours either three haemag-
glutinin (HA) genes (ha1, ha2 and ha3) in the HA cluster 
or three orfX genes (orfX1, orfX2 and orfX3) in the orfX 
cluster. Together with BoNT, these accessory proteins 
can form complexes of varying size and composition 
[7]. The variability observed in BoNTs due to the exist-
ence of seven serotypes, mosaic forms, several differ-
ent subtypes and the occurrence of BoNT in different 
complexes, as well as their heterogeneous genetic 
background are probably the main reasons for the 
spectrum of clinical presentations and disease dura-
tion associated with botulism, and pose a tremendous 
challenge to diagnostic laboratories [8].
Botulism is associated with a wide variety of foods that 
are rich in protein and kept under the partial exclu-
sion of oxygen, or in an environment where oxygen 
has been depleted by other bacteria. Marinated meat, 
fish, fruits, vegetables or mushrooms as well as home-
canned products and home-cured or smoked meat 
or fish products, which are consumed unheated, are 
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particularly known sources. BoNTs are heat-labile and 
can be destroyed by temperatures above 70 °C in min-
utes [9,10]. Nowadays, food-borne botulism is almost 
exclusively associated with home-produced foods, but 
commercial food products are occasionally involved in 
single cases or small outbreaks [11-13]. Between 2010–
2014, ECDC reported 492 cases in Europe [14], with the 
last case occurring in Slovakia in 2012 [15].
The event
In mid-August 2015 (day 0), an otherwise healthy adult 
in their 40s consumed, for dinner, three packs (100 g 
each) of a commercial hummus spread. The hummus, 
which was sold in Slovakia and the Czech Republic, had 
a best-before date of 9 days after consumption. The fol-
lowing morning (day 1), 9–11 hours after consumption 
of the hummus, the patient experienced nausea, vom-
iting, double vision, unsteady gait, dizziness, gener-
alised weakness and difficulties swallowing, and was 
admitted to hospital. Despite receiving three doses of 
equine trivalent anti-A, B and E antitoxin, the patient 
felt into a coma on day 2 and was transferred to the 
intensive care unit (ICU). As botulism is a mandatory 
notifiable disease in Slovakia, the clinic reported the 
suspected botulism case to local health authorities. A 
gastric lavage, but neither serum nor stool, was taken 
on day 2 and stored at 4 °C for further analysis. After 
one week of storage, the gastric lavage was sent to 
the Public Health Institute in Ostrava, Czech Republic 
where it tested negative by mouse bioassay. Treatment 
consisted mainly of intensive symptomatic care and 
respiratory support for almost 50 days. The patient 
was discharged from hospital after 78 days, but still 
complained about breathing problems as of their last 
follow-up in May 2017.
Methods
Epidemiological investigation
On day 1, after being notified by the clinic, the regional 
health authorities started an epidemiological investiga-
tion by interviewing the hospitalised patient. The next 
day, day 2, the patient’s household was inspected to 
check for additional cases and to collect food samples. 
There, a close relative who shares the same household 
was interviewed, a list of food items consumed by the 
patient over the last days was recorded and suspicious 
food items were collected.
In cooperation with the Slovak State Veterinary and 
Food Administration (ŠVPS), an investigation on the 
composition and the origin of the ingredients used for 
production of the hummus was conducted at the food 
processing facility.
Laboratory investigation
Isolation of Clostridium botulinum from hummus and 
molecular analysis
Small particles of hummus left on the packaging of 
the three nearly empty hummus tubes were streaked 
on tryptic soy agar and Schaedler agar plates, and 
subjected to anaerobic culture at 37 °C in anaerobic 
jars following EN ISO 7937:2005. Almost all colonies 
showed typical clostridia-like morphology and were 
probed for the presence of bont genes with a multiplex 
PCR for bont/A, bont/B, bont/E and bont/F [16] accord-
ing to CEN ISO/TS 17919:2013.
Genetic analysis
Isolates were transferred to the Consultant labora-
tory for neurotoxin-producing clostridia (botulism, 
tetanus), formerly called the Consultant Laboratory 
for Clostridium botulinum, at the Robert Koch Institute 
(RKI) in Berlin, Germany for further molecular biologi-
cal investigation. Isolates were grown in tryptone-
peptone-glucose-yeast extract (TPGY) medium at 32 °C 
in an anaerobic workstation (MG500, Don Whitley, 
Shipley, United Kingdom), and tested for the pres-
ence of bont/A–G by single and multiplex quantitative 
PCR [17]. In addition, a quantitative PCR was used to 
test for the ntnh gene as a surrogate marker for BoNT-
producing Clostridium spp. [18]. To further investigate 
the composition of the BoNT gene cluster, a set of six 
Table 
Percent identities at the nucleotide and amino acid levels of Clostridium botulinum Group I strain Banska Bystricaa 
harbouring subtype BoNT/A3 compared with C. botulinum strains harbouring other BoNT/A subtypesb
Feature
Botulinum neurotoxin subtype
A1 A1(B) A2 A3 A4 A5 A6 A7 A8
Cluster type HA orfX orfX orfX orfX HA orfX unknown orfX
Strain ATCC3502 NCTC2916 Mascarpone Loch Maree 657 1430.11 CDC41370 2008–148 Chemnitz
Nucleotide level 92.0% 91.9% 96.3% 99.9% 91.5% 92.2% 92.8% 91.9% 93.1%
Amino acid level 84.6% 84.5% 92.9% 99.8% 84.3% 85.2% 86.3% 84.9% 87.7%
BoNT: botulinum neurotoxin.
a As both of the BoNT/A-positive isolates had the identical BoNT/A sequence, only that of strain Banska Bystrica was submitted to GenBank 
under accession number KU376389.
b Only one example for each subtype (from food-borne botulism, except for subtype A4, which originated from an infant botulism case) is 
selected and compared.
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conventional PCRs targeting the three ha genes and the 
three orfX genes was applied [19]. Toxin production in 
supernatants was confirmed by in-house ELISA tests 
as described [20,21].
The 16S rRNA and bont/A gene sequences were 
obtained by Sanger sequencing [22]. Sequences were 
assembled and compared with the GenBank database 
at the National Center for Biotechnology Information 
in the United States via Geneious software packages 
(Biomatters Limited, Auckland, New Zealand) using the 
BLAST algorithm [23]. For subtyping, the amino acid 
sequence of the BoNT was compared with the eight 
known BoNT/A subtypes [4]. Sequences of the other 
BoNT/A subtypes were uploaded into Geneious and 
pairwise identities of the aligned sequences were calcu-
lated using the MAFFT algorithm [24]. For comparison, 
the BoNT subtypes of the following BoNT strains caus-
ing food-borne botulism in the past (except for BoNT/
A4 which originated from an infant botulism case) were 
selected (GenBank accession numbers in parenthe-
sis): BoNT/A1 (HA cluster) strain ATCC3502 (AM412317); 
BoNT/A1 (orfX cluster) strain NCTC2916 (X52066); 
BoNT/A2 (orfX cluster) strain Mascarpone (DQ310546); 
BoNT/A3 (orfX cluster) strain Loch Maree (CP000963); 
BoNT/A4 (orfX cluster) strain 657 (EU341307); BoNT/
A5 (HA cluster) strain 1430.11 (KC683799); BoNT/A6 
(orfX cluster) strain CDC41370 (FJ981696); BoNT/A7 
(unknown cluster) strain 2008–148 (JQ954969); BoNT/
A8 (orfX cluster) strain Chemnitz (KM233166).
Further microbiological investigation
In order to identify additional possibly contaminated 
products of the same production date, the Regional 
Authority of Public Health (RAPH) in Banská Bystrica 
investigated the products’ availability at several local 
supermarkets and the food bank. While no additional 
hummus was available from the food bank, three 
tubes of hummus with the same production date as 
the ones consumed were obtained from a supermarket. 
Unopened products were stored at 37 °C for several 
days to reach suitable conditions for C. botulinum/C. 
sporogenes germination and growth.
Results
Epidemiological investigation
Results from the interview revealed that on day 0, the 
patient alone ate scrambled eggs for breakfast; the 
patient, a close relative and a friend shared the same 
meal of mushrooms in cream sauce with pasta for 
lunch; and the patient alone ate the hummus at din-
ner after obtaining it from a food bank. The interview 
of the patient and a close relative revealed that one 
tube of the hummus product showed gas production 
prior to being opened, but it tasted normal according to 
the patient. The epidemiologists notified the Regional 
Veterinary and Food Administration of the Slovak 
Republic and the three nearly empty tubes of hummus 
and two unopened packs of a commercial ready-to-
eat sauerkraut and vegetarian sausage meal, from the 
same company as the hummus, were sent for labora-
tory investigation. Neither the scrambled eggs nor the 
pasta dish were available for sampling.
An investigation at the producing company revealed 
that the hummus product consisted of the following 
ingredients: chick peas, tofu, rapeseed oil, onion, salt, 
maize starch and spices. It also revealed that the chick 
peas originated from Brazil or Argentina.
Laboratory investigation
RAPH received the collected food items, including 
the three opened and nearly empty 100 g hummus 
tubes. Three strains with typical C. botulinum mor-
phology (designated Banska Bystrica, RAPH1223j and 
RAPH1224) were isolated, one from each tube. Two 
of them, Banska Bystrica and RAPH1223j, were PCR-
positive for the bont/A gene. The vegetarian sausage 
and sauerkraut meal tested negative for the presence 
of C. botulinum and the bont/A gene. On day 7, as soon 
as the first results were available, the hummus was 
withdrawn from the market and a Food and Feed Safety 
Alert was issued through the European Commission’s 
Rapid Alert System for Food and Feed (RASFF).
The three unopened hummus tubes with the same pro-
duction date that were obtained from a supermarket 
were subjected to 37 °C storage. Microbiological analy-
sis and PCR testing did not reveal the presence of C. 
botulinum or C. sporogenes despite some signs of gas 
formation during storage.
Molecular biological characterisation of isolated strains
The sequences of the 16S rRNA gene analysed at 
RKI revealed that all three isolates (strains Banska 
Bystrica, RAPH1223j and RAPH1224) belonged to C. 
botulinum Group I/C. sporogenes (> 99% identity), 
which are almost indistinguishable at the 16S rRNA 
sequence level [2,25]. The presence of bont/A and ntnh 
genes was confirmed by quantitative PCR, and expres-
sion of the toxin was shown by an in-house ELISA for 
isolates Banska Bystrica and RAPH1223j. From the two 
BoNT/A-positive isolates, the BoNT/A sequences were 
obtained and compared with GenBank entries at the 
nucleotide (nt) and the amino acid level. Both toxi-
genic isolates (Banska Bystrica and RAPH1223j) were 
found to harbour a bont/A gene of identical sequence; 
the bont/A sequence of one strain, Banska Bystrica, 
was submitted to GenBank under accession number 
KU376389. It showed the highest identity (≥ 99.6%) 
to bont/A sequences of the unusual subtype BoNT/
A3. Table 1 shows the distances computed against all 
BoNT/A subtypes at the nt and the amino acid levels.
Compared with the prototype BoNT/A1, the BoNT of 
the new BoNT/A-positive isolates, Banska Bystrica and 
RAPH1223j, had an identity at the amino acid level of 
only 84.6% (compared with BoNT/A1 strain ATCC3502; 
HA cluster) or 84.5% (compared with BoNT/A1 strain 
NCTC2916; orfX cluster). Similar low amino acid level 
identities (between 84.3% and 87.7%) were found when 
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compared with BoNT subtypes A4–A8, whereas amino 
acid level identity with subtype A2 (strain Mascarpone) 
was 92.9%. Sequence identities at the nt level were 
generally higher, but still diverged by up to 8.5%. Both 
isolates (Banska Bystrica and RAPH1223j) were nega-
tive for the ha1, ha2 and ha3 genes and positive for the 
orfX1, orfX2 and orfX3 genes by PCR; this is in agree-
ment with the BoNT/A3 strain Loch Maree in which the 
bont/A gene is located in the orfX cluster.
Discussion
Our laboratory investigations support the diagnosis of 
a case of food-borne botulism caused by the unusual 
BoNT subtype A3 in food consumed by the patient. To 
our knowledge, this is only the second time that this 
subtype was involved in food-borne botulism since 
eight people died from contaminated wild duck paste 
in Loch Maree, Scotland in 1922 [26]. No other strain 
belonging to this specific A3 subtype was isolated or 
subtyped for nearly a century until Lúquez and col-
leagues identified three strains from Argentina (in 
soil and salad) in 2012 [27]. Interestingly, the two 
described BoNT/A-positive isolates have an identical 
BoNT/A sequence at the amino acid level as one of the 
strains (CDC54054) isolated from Argentinian soil [27], 
and the chick peas used in the hummus consumed by 
the patient originated from South America, either from 
Brazil or Argentina.
Initially, suspected botulism could not be confirmed by 
testing the gastric lavage taken on day 2. Considering 
the acidity and proteolytic activity, as well as the 
length of storage, the gastric lavage taken after eme-
sis on day 1 was not an ideal sample. Serum and stool 
samples, which have been proposed to be the most 
reliable samples for diagnostic testing [28], might 
not have been collected, because of a lack of testing 
facilities and inexperienced clinical personnel, par-
ticularly since botulism is a rare disease and no cases 
have been notified in Slovakia since 2012 [15]. For the 
clinician, it is important to consider the optimal tim-
ing when choosing samples for botulism diagnosis. 
Despite demonstration of BoNT in serum as one of the 
key tests to confirm botulism, the time period in which 
BoNT can be detected from serum is usually limited to 
the first few days after oral ingestion. However, confir-
mation of BoNT-producing Clostridium species (spores) 
from faeces can often be achieved over a more pro-
longed period (up to two weeks) [28,29]. Therefore, 
co-examination of serum and stool is recommended to 
confirm clinical cases of food-borne botulism [28-31]. 
The mere detection of C. botulinum from faeces with-
out clinical symptoms does not imply the presence of 
botulism given that C. botulinum spores are not usually 
detected in the faeces of healthy humans. However, on 
rare occasions, spores that have been ingested with 
naturally contaminated food (e.g. honey, fresh veg-
etables) might be detected in the faeces of otherwise 
healthy people [28].
In our case, food-borne botulism could only be con-
firmed by the isolation of C. botulinum from two of the 
three consumed tubes of hummus. It is always hard to 
exclude that the analysed food become cross-contam-
inated in the household with C. botulinum by handling 
with kitchen utensils contaminated via another food. 
However, there was no indication that the hummus 
became cross-contaminated within the patient’s house-
hold. In the aftermath of the current botulism case, 
three unopened hummus tubes with the same produc-
tion date were subjected to 37 °C storage and analysed 
for the presence of C. botulinum without any positive 
result. It is not unusual that C. botulinum cannot be 
detected from other items of the same lot. In three 
botulism outbreaks in Europe in 2011, which involved 
commercial olive tapenade, almond-stuffed olives and 
korma sauce, C. botulinum and BoNT could only be 
identified from one or two opened jars/pots obtained 
from the households, but not from any unopened jars/
pots from the same lot (consisting of 60, 900, and 1,836 
items, respectively) that were tested [11,32-34]. These 
cases indicate that even in modern industrialised food 
production, contamination of a single or a very few 
items within a lot cannot be completely excluded. In 
all those cases, consumer protection had utmost prior-
ity and food recalls were issued solely on the basis of 
positive results from the remaining product in the open 
containers from the affected households to prevent a 
potential spread of the disease [32-34].
Hummus has been involved in a food-borne botulism 
outbreak in the past, possibly due to incorrect stor-
age temperature [35]. Whether this was the case in 
the event presented here could not be determined, 
but the patient did notice gas formation in the prod-
ucts. This might be indicative of spoilage as growth of 
C. botulinum in spoiled products is often associated 
with gas production, e.g. foaming, bulging of cans [36]. 
However, unlike Group II strains of C. botulinum which 
can grow at refrigeration temperatures, Group I strains 
(to which this study’s isolated strains belong) require 
growth temperatures above 10 °C [2]. This suggests 
that the hummus product was at least partially stored 
above refrigeration temperatures.
Compared with the known eight BoNT/A subtypes 
(BoNT/A1 to BoNT/A8 [4]), the subtype A3 is both very 
rare and the most distant from the prototype BoNT/A1 
(Table 1), being up to 15.4% and 8% different at the 
amino acid and nt level, respectively. Notably, because 
of its amino acid sequence divergence, BoNT/A3 is 
known to be neutralised less efficiently by polyclonal 
antibodies generated against BoNT/A1 [37]. This has 
led us to speculate that the long lasting neurological 
effects observed in the patient despite the administra-
tion of three doses of trivalent antitoxin might at least 
be partially due to suboptimal neutralisation by the 
antitoxin, which is directed against BoNT/A1.
The rareness and divergence of the BoNT/A3 sub-
type poses the risk that it might not be detected by 
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immunological or sequence-based diagnostic assays 
that have not been validated against it. In fact, one 
ELISA has already been shown to be unable to detect 
it [38]. Furthermore, in one [39] of the four men-
tioned PCR methods in ISO ISO/TS 17919:2013, the 
sequence of one primer and the probe each contain 
one mismatch towards all BoNT/A3 sequences. These 
mismatches might therefore hamper identification of 
strains belonging to the A3 subtype by the correspond-
ing PCR [40,41]. Testing laboratories should be aware 
that strains harbouring this rare subtype can occur in 
European countries and are advised to validate their 
methods accordingly. Unfortunately, the exchange of 
BoNT-producing strains and in some instances, even 
the sharing of their sequence information are restricted 
because of their nature as possible biowarfare agents 
and other dual-use concerns [42,43].
Conclusion
Rare and novel BoNT sequence variation can especially 
easily escape detection by sequence-based or immu-
nological methods. As more sequences become avail-
able despite some restrictions, diagnostic facilities 
should check their PCRs frequently to ensure inclusion 
of all known sequence variations.
As a result of the rareness of botulism, many laborato-
ries have no or only individual assays for detection at 
hand. Specialised laboratories (e.g. national reference 
laboratories or consultant laboratories) able to apply a 
broader range of methods could aid those laboratories, 
but are often not easily identifiable by the laboratories 
responsible for testing the samples.
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